These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23506344)

  • 1. A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers.
    Harding K; Sumner M; Cardinal M
    Int Wound J; 2013 Apr; 10(2):132-7. PubMed ID: 23506344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of venous leg ulcers with Dermagraft.
    Omar AA; Mavor AI; Jones AM; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):666-72. PubMed ID: 15121121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot multi-centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers.
    Hayes PD; Harding KG; Johnson SM; McCollum C; Téot L; Mercer K; Russell D
    Int Wound J; 2020 Jun; 17(3):742-752. PubMed ID: 32103603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
    Marston WA; Hanft J; Norwood P; Pollak R;
    Diabetes Care; 2003 Jun; 26(6):1701-5. PubMed ID: 12766097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
    Fitzgerald RH; Sabolinski ML; Skornicki M
    Wound Manag Prev; 2019 Sep; 65(9):26-34. PubMed ID: 31702990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft.
    Sanders L; Landsman AS; Landsman A; Keller N; Cook J; Cook E; Hopson M
    Ostomy Wound Manage; 2014 Sep; 60(9):26-38. PubMed ID: 25211605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
    Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
    J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
    Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
    J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
    Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Slade HB
    Lancet; 2012 Sep; 380(9846):977-85. PubMed ID: 22863328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibroblast-derived dermal substitute: results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers.
    Warriner RA; Cardinal M;
    Adv Skin Wound Care; 2011 Jul; 24(7):306-11. PubMed ID: 21685733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for helping people adhere to compression treatments for venous leg ulceration.
    Weller CD; Buchbinder R; Johnston RV
    Cochrane Database Syst Rev; 2013 Sep; (9):CD008378. PubMed ID: 24009097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomised trial of four-layer versus short stretch compression bandages for the treatment of venous leg ulcers.
    Scriven JM; Taylor LE; Wood AJ; Bell PR; Naylor AR; London NJ
    Ann R Coll Surg Engl; 1998 May; 80(3):215-20. PubMed ID: 9682649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manuka honey vs. hydrogel--a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers.
    Gethin G; Cowman S
    J Clin Nurs; 2009 Feb; 18(3):466-74. PubMed ID: 18752540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.
    Falanga V; Margolis D; Alvarez O; Auletta M; Maggiacomo F; Altman M; Jensen J; Sabolinski M; Hardin-Young J
    Arch Dermatol; 1998 Mar; 134(3):293-300. PubMed ID: 9521027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
    Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
    Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis.
    Hanft JR; Surprenant MS
    J Foot Ankle Surg; 2002; 41(5):291-9. PubMed ID: 12400712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre, randomised controlled trial of four-layer bandaging versus short-stretch bandaging in the treatment of venous leg ulcers.
    Partsch H; Damstra RJ; Tazelaar DJ; Schuller-Petrovic S; Velders AJ; de Rooij MJ; Sang RR; Quinlan D
    Vasa; 2001 May; 30(2):108-13. PubMed ID: 11417280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.